USPTO serial 76178478
ARDANA BIOSCIENCE
Reviewed by CopyMark Law Group
Reg. 3147061Status 710
- Filing date
- Status date
- Registration date
- Sep 26, 2006
- Examiner
- SOUDERS, MICHAEL J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ARDANA BIOSCIENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LONDON, GB
LONDON, GB
LONDON, ENGLAND, GB
London N1 6AA, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARK H. TIDMAN
ANN K FORD ESQ DLA PIPER RUDNICK GRAY CARY US LLP1200 19TH ST NWWASHINGTON, DC 20036-2412UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for medical diagnosis, namely, for the diagnosis of pregnancy; sanitary preparations, namely, tampons used for delivering pharmaceutical preparations to the female reproductive tract and tampons designed to reduce the chance of infection of the female reproductive tract; sanitary pads; sanitary napkins; dietetic products for medical use, namely, dietary supplements and food for medical restricted diets; diagnostic kits consisting primarily of medical diagnostic reagents and preparations for reproductive health uses, semen analysis, testing sperm fertilization capability, hormone level analysis for testing the presence and level of Luteneising Hormone (LH), Follicle Stimulating Hormone (FSH), Beta-Oestradiol, Prolactin, Progesterone, Human Chorionic Gonadotrophin (hCG) and Testosterone, to detect genital infections, to test for antibodies to various organisms, to detect markers of pre-term labor, pregnancy complications, miscarriage and implantation failure, to detect antiphospholipids, protein S deficiency, lupus anti-coagulant and factor V Leiden mutation, to detect markers of female fertility, to detect DAZL heterozygous mutation and associated biochemical markers such as testosterone for the analysis of DNA, RNA for the detection of disease or predisposition associated with reproduction, for the analysis of protein or other biochemical markers of disease or predisposition of disease, to detect biochemical markers which indicate disease or predisposition to disease; oral contraceptives; contraceptive foams | SECTION 8 - CANCELLED | — |
| 010 | diagnostic kits consisting primarily of dipsticks, litmus paper, test-tubes, pipettes, stylets for drawing blood samples, plastic containers, slides, syringes, needles, spatulas and non-invasive devices, and medical diagnostic reagents and preparations for obtaining and testing biological samples for reproductive health uses, semen analysis, testing sperm fertilization capability, hormone level analysis for testing the presence and level of Luteneising Hormone (LH), Follicle Stimulating Hormone (FSH), Beta-Qestradiol, Prolactin, Progesterone, Human ChorionicGonadotrophin (hCG) and Testosterone, to detect genital infections, to test for antibodies to various organisms, to detect markers of pre-term labor, pregnancy complications, miscarriage and implantation failure, to detect antiphospholipids, protein S deficiency, lupus anti-coagulant and factor V Leiden mutation, to detect markers of female fertility, to detect DAZL heterozygous mutation and associated biochemical markers such as testosterone for the analysis of DNA, RNA for the detection of disease or predisposition associated with reproduction, for the analysis of protein or other biochemical markers of disease or predisposition of disease, to detect biochemical markers which indicate disease or predisposition to disease; surgical and medical apparatus, namely, dipsticks, litmus paper, test-tubes, pipettes, stylets for drawing blood samples, plastic containers, slides, syringes, needles, spatulas and non-invasive devices for obtaining and testing biological samples; diaphragms for contraception; coils for contraception; protective sheaths for contraception | SECTION 8 - CANCELLED | — |
| 035 | medical assistance, namely the provision of medical support staff to clinics and medical practices for the screening of patients, auditing and maintenance of records, and consultation regarding diagnoses and treatment options; nursing services, namely providing nursing staff to doctors, clinics, hospitals and medical practices | SECTION 8 - CANCELLED | — |
| 042 | Scientific research and development of new products for others; technical consultation and research in the fields of health, wellbeing, nursing, medicine and healthcare | SECTION 8 - CANCELLED | — |
| 044 | Healthcare services; medical clinics; midwife services; provision of information relating to health, wellbeing, nursing, medicine and healthcare via the Internet | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ARDANA BIOSCIENCE LIMITED
- Other trademarks owned by ARDANA BIOSCIENCE LIMITED
- Other trademarks owned by ARDANA BIOSCIENCE LIMITED
- Other trademarks owned by Coarsedata Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ARDANA BIOSCIENCE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2013 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Sep 26, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2006 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jul 7, 2006 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jul 7, 2006 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| May 24, 2006 | ICNA | NOTICE OF ALLOWANCE CORRECTION ENTERED | — |
| May 2, 2006 | FAXX | FAX RECEIVED | — |
| Jan 10, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 18, 2005 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 28, 2005 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 19, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 18, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 9, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2005 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 1, 2005 | ALIE | ASSIGNED TO LIE | — |
| May 31, 2005 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 31, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 31, 2005 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 16, 2005 | CWBP | WITHDRAWN BEFORE PUBLICATION | — |
| Feb 16, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 14, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 31, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jan 25, 2005 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 25, 2005 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 25, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 25, 2005 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Dec 17, 2004 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 4, 2004 | ALIE | ASSIGNED TO LIE | — |
| Sep 29, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 29, 2004 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 24, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 24, 2004 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2003 | CFIT | CASE FILE IN TICRS | — |
| Oct 24, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 24, 2003 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 25, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 21, 2003 | PAPER RECEIVED | — | |
| Sep 23, 2002 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jul 17, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 5, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 15, 2001 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Oct 11, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 11, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 4, 2001 | DOCK | ASSIGNED TO EXAMINER | — |